From 2004 to 2010 Fei was involved in the teaching of undergraduate biochemistry courses including 2EE3, 3C03 and 4C03 as teaching assistant in Faculty of Health Sciences at McMaster University.
Pharmaceutical Industrial Experience:
From 2012 to 2013, Fei joined SGS Life Sciences as Scientist in Biotechnology. Fei conducted the analytical method development and method validation involved in protein drug development. Fei has in-depth knowledge of pharmaceutical industry guidelines such as Good Manufacturing Practice (GMP) and healthcare compliance policies.
Fei specializes in the research areas of cancer biology, biochemistry and cell biology. Fei is the member of American Society of Cell Biology (ASCB) and American Association of Cancer Research (AACR).
Fei graduated from Jining Medical College in China in 2001. As he practised clinical medicine as an intern, Fei realized the lack of effective therapy for diseases such as cancer and thus decided to develop his career into the basic research on cancer therapeutics. In 2004 Fei received his Master degree in Biochemistry at Fudan University and successfully discovered the prognostic biomarker for lung cancer patients based upon the results from the biochemical studies as well as the statistical analysis of clinical studies.
In 2004 Fei came to Canada and started his PhD studies on the molecular mechanisms of breast cancer cell death under the supervision of Dr. David Andrews and Dr. Brian Leber in Department of Biochemistry and Biomedical Sciences at McMaster University. During the PhD studies, Fei discovered a novel cancer cell death signaling pathway, which could be utilized to treat the recurrent breast cancer that is resistant to the chemotherapy.
In May 2013 Fei joined the Bachelor of Technology Program as Assistant Professor.